ArticleJournal of translational medicine2026
Umbilical cord mesenchymal stromal cells-derived HGF inhibits STING-mediated pyroptosis to alleviate cerebral ischemia/reperfusion injury via c-Met/β-catenin/RNF5 pathway.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundPyroptosis plays an essential role in the pathological process of cerebral ischemia/reperfusion (I/R) injury. Hepatocyte growth factor (HGF)-modified stem cells improve brain I/R damage. This research investigated whether umbilical cord mesenchymal stromal cells (UCMSCs)-derived HGF affected pyroptosis post brain I/R injury.
methodsRats were subjected to middle cerebral artery occlusion (MCAO), and neurons (H19-7 or HT-22) were exposed to oxygen-glucose deprivation/reperfusion (OGD/R), to establish cerebral I/R injury models in vivo and in vitro. Exosomes were isolated from UCMSCs, before added into cells. Brain injury was assessed by triphenyltetrazolium chloride (TTC) staining, modified neurological severity score (mNSS), and hematoxylin and eosin staining. Cell viability and pyroptosis were assessed using cell counting kit-8 (CCK-8) and flow cytometry, respectively. Inflammatory cytokines interleukin (IL)-18 and IL-1β were detected with enzyme-linked immunosorbent assay (ELISA). Protein expressions were measured by western blot and immunohistochemistry. The interactions between molecules were determined using co-immunoprecipitation, chromatin immunoprecipitation, and dual-luciferase assay.
resultsRing finger protein 5 (RNF5) was downregulated, and stimulator of interferon gene (STING) was activated in MCAO rats and OGD/R-exposed cells. RNF5 mediated ubiquitination and degradation of STING. RNF5 overexpression inhibited STING-mediated pyroptosis in OGD/R-treated cells. UCMSCs-exosomes suppressed pyroptosis, which was reversed when silencing HGF in UCMSCs-exosomes or adding with cellular mesenchymal-epithelial transition factor (c-Met) inhibitor. The effects of HGF-silenced UCMSCs-exosomes were overturned by activating c-Met. β-catenin recruited T-cell factor 4 (TCF4) to promote RNF5 transcription. HGF-overexpressed UCMSCs-exosomes repressed pyroptosis, which was counteracted by RNF5 knockdown.
conclusionUCMSCs-derived exosomal HGF attenuated cerebral I/R injury through inhibiting STING-mediated pyroptosis via c-Met/β-catenin/RNF5 pathway. Our study provided a promising therapeutic strategy for brain I/R damage.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.